Skip to main content

Closed

NUVL: Nuvalent, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-35.1%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-34.1×

Current ratio16.14×

Nuvalent, Inc.

NUVLNASDAQ Global Select·USD·Closed

Nuvalent, Inc.

NUVLNASDAQ·USD·Closed

$123.96

+0.00%

$123.96

+$0.00 (0.00%)

52W Range

100thpctl

Volume

-

Mkt Cap

9.13BUSD

P/E

-20.5TTM

Div Yield

–ann

52W Range

100thpctl

Volume

-

Market Cap

9.13BUSD

P/E Ratio

-20.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings